Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-23-067149

Chief Executive Officer bought 20,000 shares at $2.05 ($41,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Imran Talat Chief Executive Officer 2023-11-29 Purchase +20,000 $2.05 $41,000 469,455 D
Open-market purchases · 20,000 sh · avg $2.05 · $41,000
Loading xslF345X05/ownership.xml…